Entero Healthcare Solns Valuation Multiples

Entero Healthcare Solns is valued at $684M as of October 2026, a 0.9x revenue multiple. In the last 12 months, Entero Healthcare Solns revenue was $794M and Entero Healthcare Solns EBITDA was $37M.

Entero Healthcare Solns Overview

About Entero Healthcare Solns

Distributes medical devices, pharmaceuticals, diagnostics products and other healthcare supplies to hospitals, pharmacies and clinics across India. Also runs a platform for provider ordering. Based in Mumbai.


Founded

2018

HQ

India

Employees

5.0K

Financials (LTM)

Revenue: $794M
EBITDA: $37M

EV

$731M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Entero Healthcare Solns Financials

Entero Healthcare Solns reported last 12-month revenue of $794M and EBITDA of $37M.

In the same LTM period, Entero Healthcare Solns generated $37M in EBITDA and $16M in net income.


Entero Healthcare Solns P&L

In the most recent fiscal year, Entero Healthcare Solns reported revenue of $691M and EBITDA of $27M.

Entero Healthcare Solns is profitable as of last fiscal year, with gross margin of 10%, EBITDA margin of 4%, and net margin of 2%.

See analyst estimates for Entero Healthcare Solns
LTMLast FY202320242025202620272028
Revenue$794M$691M$395M$504M$652M
Gross Profit-$66M$32M$45M$62M
Gross Margin-10%8%9%9%
EBITDA$37M$27M$10M$16M$25M
EBITDA Margin5%4%3%3%4%
EBIT Margin4%3%2%3%3%
Net Profit$16M$12M$3M$9M$12M
Net Margin2%2%1%2%2%
Net Debt-$47M---

Financial data powered by Morningstar, Inc.

Entero Healthcare Solns Stock Performance

Entero Healthcare Solns has current market cap of $684M, and enterprise value of $731M.


Entero Healthcare Solns' stock price is $15.69.

Entero Healthcare Solns share price decreased by 12.0% in the last 30 days, and increased by 25.9% in the last year.

Entero Healthcare Solns has an EPS (earnings per share) of $0.28.

See more trading valuation data for Entero Healthcare Solns
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$731M$684M-1.0%-12.0%20.5%25.9%$0.28

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Entero Healthcare Solns Valuation Multiples

Entero Healthcare Solns trades at 0.9x EV/Revenue multiple, and 19.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Entero Healthcare Solns

Entero Healthcare Solns Financial Valuation Multiples

As of October 22, 2026, Entero Healthcare Solns has market cap of $684M and EV of $731M.

Entero Healthcare Solns has a P/E ratio of 42.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.9x1.1x1.8x1.4x1.1x
EV/EBITDA19.6x26.8x72.0x44.9x29.3x
EV/EBIT21.9x31.0x92.1x53.9x34.1x
EV/Gross Profit-11.0x22.8x16.4x11.8x
P/E42.8x56.2x244.7x80.0x58.8x
EV/FCF(85.1x)241.3x(65.2x)(74.2x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Entero Healthcare Solns Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Entero Healthcare Solns Margins & Growth Rates

Entero Healthcare Solns grew revenue by 27% and EBITDA by 64% in the last fiscal year.

In the most recent fiscal year, Entero Healthcare Solns reported gross margin of 10%, EBITDA margin of 4%, and net margin of 2%.

See estimated margins and future growth rates for Entero Healthcare Solns

Entero Healthcare Solns Margins

Last FY202420252026202720282029
Gross Margin10%9%9%8%
EBITDA Margin4%3%4%5%
EBIT Margin3%3%3%4%
Net Margin2%2%2%2%
FCF Margin0%(2%)(0%)1%

Entero Healthcare Solns Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth27%28%29%27%
Gross Profit Growth-39%39%7%
EBITDA Growth64%60%53%62%
EBIT Growth75%71%58%72%
Net Profit Growth55%206%36%48%
FCF Growth52%(12%)(99%)(7357%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Entero Healthcare Solns Operational KPIs

Entero Healthcare Solns' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Entero Healthcare Solns' Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Entero Healthcare Solns' Rule of X is 73% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Entero Healthcare Solns
LTMLast FY202320242025202620272028
Rule of 4027%32%---
Bessemer Rule of X60%73%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-1%1%1%1%
Opex to Revenue-6%6%6%6%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Entero Healthcare Solns Competitors

Entero Healthcare Solns competitors include Standard Engineering Tech, Genky Drug Stores, Doman Building Materials, Momentum Group AB, Alligo, Salus, Thermador Groupe, Zjamp Group, Ghitha Holding and Paul Hartmann.

Most Entero Healthcare Solns public comparables operate across Medical Supplies, Wholesale Distribution and Pharmacies.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Standard Engineering Tech$82M$12M8.3x8.6x54.2x46.3x
Genky Drug Stores$1.4B$117M0.6x0.6x7.3x7.4x
Doman Building Materials$2.2B$180M0.6x0.6x7.8x7.6x
Momentum Group AB$313M$45M2.3x2.1x16.1x14.4x
Alligo$965M$98M1.0x0.9x9.5x7.0x
Salus$782M$31M0.9x-21.8x-
Thermador Groupe$563M$80M1.0x1.0x7.1x6.6x
Zjamp Group$7.1B$249M0.1x-2.7x-

This data is available for Pro users. Sign up to see all Entero Healthcare Solns competitors and their valuation data.

Start Free Trial

Acquisitions by Entero Healthcare Solns

Entero Healthcare Solns has acquired 1 company to date.

Last acquisition by Entero Healthcare Solns was on March 20th 2025. Entero Healthcare Solns acquired Aayu by MedCords for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Entero Healthcare Solns

Aayu by MedCords
Description
Aayu by MedCords is a healthcare platform that digitizes retail medical stores across underserved regions of India outside the top fifteen cities. It organizes the fragmented network serving the domestic retail pharmaceutical market to enable access to urban-grade products and teleconsultations from specialist doctors. Leveraging ONDC infrastructure, Aayu connects direct-to-consumer healthcare brands with omni-channel distribution through its extensive chemist store partnerships.
HQ CountryIndia
HQ City
-
Deal Date20 Mar 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Entero Healthcare Solns acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Entero Healthcare Solns

When was Entero Healthcare Solns founded?Entero Healthcare Solns was founded in 2018.
Where is Entero Healthcare Solns headquartered?Entero Healthcare Solns is headquartered in India.
How many employees does Entero Healthcare Solns have?As of today, Entero Healthcare Solns has over 5K employees.
Who is the CEO of Entero Healthcare Solns?Entero Healthcare Solns' CEO is Prabhat Agrawal.
Is Entero Healthcare Solns publicly listed?Yes, Entero Healthcare Solns is a public company listed on National Stock Exchange of India.
What is the stock symbol of Entero Healthcare Solns?Entero Healthcare Solns trades under ENTERO ticker.
When did Entero Healthcare Solns go public?Entero Healthcare Solns went public in 2024.
Who are competitors of Entero Healthcare Solns?Entero Healthcare Solns main competitors include Standard Engineering Tech, Genky Drug Stores, Doman Building Materials, Momentum Group AB, Alligo, Salus, Thermador Groupe, Zjamp Group, Ghitha Holding, Paul Hartmann.
What is the current market cap of Entero Healthcare Solns?Entero Healthcare Solns' current market cap is $684M.
What is the current revenue of Entero Healthcare Solns?Entero Healthcare Solns' last 12 months revenue is $794M.
What is the current revenue growth of Entero Healthcare Solns?Entero Healthcare Solns revenue growth (NTM/LTM) is 22%.
What is the current EV/Revenue multiple of Entero Healthcare Solns?Current revenue multiple of Entero Healthcare Solns is 0.9x.
What is the current EBITDA of Entero Healthcare Solns?Entero Healthcare Solns' last 12 months EBITDA is $37M.
What is Entero Healthcare Solns' EBITDA margin?Entero Healthcare Solns' last 12 months EBITDA margin is 5%.
What is the current EV/EBITDA multiple of Entero Healthcare Solns?Current EBITDA multiple of Entero Healthcare Solns is 19.6x.
What is the current FCF of Entero Healthcare Solns?Entero Healthcare Solns' last 12 months FCF is ($9M).
What is Entero Healthcare Solns' FCF margin?Entero Healthcare Solns' last 12 months FCF margin is (1%).
What is the current EV/FCF multiple of Entero Healthcare Solns?Current FCF multiple of Entero Healthcare Solns is (85.1x).
How many companies Entero Healthcare Solns has acquired to date?As of October 2026, Entero Healthcare Solns has acquired 1 company.
What was the largest acquisition by Entero Healthcare Solns?None of the M&A deals Entero Healthcare Solns has completed have disclosed valuations.
What companies Entero Healthcare Solns acquired?Entero Healthcare Solns acquired Aayu by MedCords.
In how many companies Entero Healthcare Solns has invested to date?Entero Healthcare Solns hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Entero Healthcare Solns

Lists including Entero Healthcare Solns

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial